
    
      This Phase 2, multicenter, randomized, double-blind, placebo-controlled clinical trial will
      evaluate the efficacy and safety of intravenous Sodium Nitrite Injection for treatment of
      patients infected with COVID-19 who develop lung injury and require mechanical ventilation.
      The primary objective is to compare the two treatment groups with respect to the proportion
      of study subjects who are alive and free of respiratory failure at Day 28.
    
  